Elevated baseline CTC counts are linked to worse overall survival, progression-free survival, and treatment response in cancer patients. In prostate cancer, patients with five or more CTCs at ...

Please provide your email address to receive an email when new articles are posted on . Men with five or more circulating tumor cells/7.5 mL at baseline had a more than threefold risk for death ...

Circulating tumor cells were first described in 1869 by Thomas Ashworth, an Australian pathologist who observed them in a peripheral blood sample taken from a patient with metastatic cancer. 1 They ...

Improved methods for circulating tumor cell capture and analysis can ensure reproducible biomarker and omics insights across different cancer types. Mouadh Barbirou, is a molecular biologist at the ...

Circulating tumor cells (CTCs) are malignant cells that have detached from primary or metastatic tumor sites and entered the peripheral bloodstream. As a critical component of liquid biopsy, the ...

Tumor cells circulating in the blood are the 'germ cells' of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...

One of cancer’s deadliest tricks is its ability to spread to other organs. An existing cardiac drug has now been found to reduce the risk of metastasis by dissolving circulating clusters of breast ...

Hepatocellular carcinoma (HCC) is a significant global health concern, particularly in regions like the Asia-Pacific, where chronic viral hepatitis and liver diseases contribute to its high incidence ...

Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulating tumor ...